SAGA Diagnostics AB
- Home
- Companies
- SAGA Diagnostics AB
- Services
- Liquid Biopsy Treatment
Liquid Biopsy Treatment
In direct comparisons, ctDNA has been shown to be superior to conventional serum protein biomarkers, circulating tumor cells, and radiographic imaging. Analysis of ctDNA in liquid biopsies is rapidly becoming one of the most important minimally invasive diagnostic methods used in oncology since it has overcome the many limitations of traditional diagnostic methods used today.
Most popular related searches
liquid biopsy
circulating cancer cell
cancer cell
biopsy
radiography imaging
biopsy testing
biopsy test
tumor dna
circulating dna
circulating biomarker
Treatment decisions will rely more and more on the genetic variant profile of a tumor derived from the patient’s cancer cells. Thus, liquid biopsy tests that can capture and analyze tumor cells and/or circulating tumor DNA hold great promise for current and future cancer applications.